Can you get weight loss injections without contacting your GP?

Do you legally need GP involvement to access weight loss injections?

Not for private treatment. UK law requires that Mounjaro and Wegovy are prescribed by a qualified prescriber following a clinical assessment, it does not specify that prescriber must be a GP. GPhC-registered Independent Prescribers, which include qualified pharmacist prescribers and nurse prescribers, have the legal authority to assess patients and issue prescriptions for these medicines in their own right.

What this means in practice: you can complete a private consultation and receive a prescription for weight loss injections without a GP referral, have a real clinician review your answers the same day, and receive a prescription without setting foot in a GP surgery. The assessment still covers your BMI, medical history, current medicines, and any conditions that might affect suitability. A prescriber who skips that process (regardless of whether they are a GP or not) is not practising safely.

One habit worth building before you order from any online pharmacy: spend thirty seconds on the GPhC pharmacy register and confirm the pharmacy's registration number is listed. It takes less time than making a cup of tea, and it is the single fastest way to separate a legitimate service from an unregulated seller.

At nume, every consultation is personally read by a GPhC-registered Independent Prescriber, a real clinician, not an automated scoring system. You can read more about our clinical team if you want to know who is reviewing your case.

What role does a GP actually play on the private route?

Your GP is notified, not consulted. Under GPhC guidance and NHS England's clinical framework for weight-management injections, the prescribing pharmacist or clinician is expected to inform your GP that treatment has begun. This is a professional courtesy and a safety measure, if you later attend your GP surgery with a side effect or a change in health, your doctor has the context they need.

That notification goes from the prescribing service to your surgery. You do not need to arrange it, request it, or speak to your GP first. It happens in the background, and it does not create a gatekeeping step where your GP can block or delay your private prescription.

Some people worry that their GP will disapprove. That concern is understandable, but it does not affect the legal or clinical process. Private prescribing sits outside the NHS pathway; your GP does not approve or deny it. If you have questions about whether to involve your GP more actively, that is worth discussing with your prescriber, particularly if your GP manages other conditions that might interact with treatment.

Are the safety checks any lighter without a GP involved?

No, and this is worth being direct about, because some sellers exploit the phrase 'no GP needed' to imply that clinical scrutiny has been removed. It has not, at any legitimate pharmacy. The NHS's guidance on tirzepatide makes clear that these medicines carry a real side-effect profile and genuine contraindications; they are not suitable for everyone who asks for them.

A regulated private service runs its own safety infrastructure. At nume that includes photo-ID verification, live weight confirmation by video, a review of your Summary Care Record where appropriate, and a full prescriber assessment of your medical history before anything is dispatched. Transfer patients and anyone requesting a dose increase are asked to provide supporting evidence. None of that is lighter than a GP appointment, in some respects it is more systematic.

The risk sits elsewhere: with unregistered sellers who offer these medicines without a prescription and without any clinical review. The MHRA has warned publicly about counterfeit weight-loss pens circulating online, some of which have contained insulin. If a seller does not appear on the GPhC register and does not require a clinical assessment, that is a serious red flag, not a convenience. You can find guidance on what to look for when sourcing injections safely as a starting point.

For a fuller picture of the trade-offs involved in this treatment, the drawbacks of weight loss injections are worth reading before you start, side effects, the commitment to lifestyle changes alongside treatment, and what happens if you stop.

Who can access private weight loss injections, and what determines suitability?

The licensed eligibility criteria for Mounjaro and Wegovy are set by the medicines' UK licences, not by NHS thresholds. For weight management, both are licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition, for example, high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. BMI alone is not the whole picture. The prescriber reviews the complete clinical context before approving treatment.

Private treatment does not require a BMI of 35, it does not require a referral to a specialist service, and it is not rationed by the phased NHS rollout criteria that currently limit NHS access to people with higher BMIs and multiple conditions. That is precisely why many people who want to start now, rather than wait, explore the private route. A clear overview of how these injections are used for weight management in the UK covers the medicines, the licences, and the evidence in more detail.

If you are ready to find out whether you are clinically suitable, a free consultation with our prescribers is the place to start. There is no obligation, no subscription, and no referral to arrange. Start your free consultation and a GPhC-registered prescriber will review your case the same day.